Plant Comparison
Saffron vs Fenugreek
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Saffron and Fenugreek: they share 6 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cancer (anticancer research), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Saffron | Fenugreek | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 8/10 | Stronger for Fenugreek |
| Blood sugar / diabetes support | 1/10 | 7/10 | Stronger for Fenugreek |
| Cancer (anticancer research) | 8/10 | 7/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 7/10 | Stronger for Fenugreek |
| Metabolic support | 1/10 | 7/10 | Stronger for Fenugreek |
| Skin irritation | 1/10 | 7/10 | Stronger for Fenugreek |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.
The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.
The main bitter-tasting glycoside of the stigma, a precursor of safranal.
Thought to contribute to the antidiabetic and cholesterol-lowering effects.
Mucilaginous soluble fiber that slows carbohydrate absorption, a key mechanism behind the blood-sugar-lowering effect.
An unusual amino acid studied for insulin-potentiating activity.
Aromatic lactone responsible for fenugreek's characteristic maple-syrup smell, including the body-odor effect reported with supplementation.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.
Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).
Fenugreek appears https://www.nccih.nih.gov/health/fenugreek for most people.
Less serious side effects like diarrhea and indigestion have been reported anecdotally. You may also experience https://pubmed.ncbi.nlm.nih.gov/26251835/, which could be harmful if you have an eating disorder or are trying to https://www.healthline.com/nutrition/how-to-gain-weight. Moreover, some people report a strange and slightly sweet body odor when supplementing, but this is unconfirmed. Given its effect on blood sugar, fenugreek should be used with caution if you’re taking diabetes medication or other supplements that lower blood sugar levels.
Duke (2002) provides strong clinical evidence (score 2) for fenugreek's hypoglycemic and hypocholesterolemic activities — among the best-evidenced herbal treatments for blood sugar and lipid management. Anti-inflammatory and demulcent activities also have clinical support. The seed is Commission E approved as an appetite stimulant. Dose: 6–50 g of ground seeds daily for blood sugar management; 1–4 g seeds in tea for digestive use. The plant has lactagogue effects and can cause maple syrup-like body odor due to sotolon content. Contraindicated in pregnancy at medicinal doses due to uterotonic effects (Duke, 2002).
External Ids
Botanical Description
Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.
Erect annual herb with trifoliate leaves, each leaflet oblong and finely toothed toward the tip. Small, pale yellow to white, pea-like flowers are borne singly or in pairs in the leaf axils, followed by long, slender, curved seed pods.[11]
Habitat
Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.
Cultivated widely as a food and forage crop; native to the eastern Mediterranean and western Asia, now grown throughout South Asia, the Middle East and North Africa.[11]
Harvesting
The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.
Leaves and young sprouts are harvested throughout the growing season; seed pods are collected when fully mature and dried, then the hard seeds are threshed out.[11]
Traditional Uses
Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]
Fenugreek seed has an ancient tradition across the Mediterranean, Middle East and South Asia as a digestive and appetite-stimulant remedy and lactation aid, and modern clinical research strongly supports its traditional use for blood sugar and cholesterol management, formalised in Commission E approval as an appetite stimulant.[5, 11, 12]
Preparations
Stigma extract standardised to safranal/crocin content, taken as capsules; the form used in most clinical mood and metabolic studies.
Ground seeds taken with food, or whole seeds soaked/simmered as a tea, the traditional preparation for digestive and blood sugar support.
Standardized seed extract in capsule form, the form most used in clinical trials on blood sugar and cholesterol.
Dosage
Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
Pairings
Not documented
Fenugreek and bitter melon can each lower blood sugar, so taking them together — especially alongside diabetes medicines — may add up and increase the risk of hypoglycaemia. Monitor your blood glucose.[15, 16]
Fenugreek and black seed (Nigella sativa) can each lower blood sugar, so taking them together — especially alongside diabetes medicines — may add up and increase the risk of hypoglycaemia. Monitor your blood glucose.[15, 17]
References & Sources
- Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
https://doi.org/10.1093/nutrit/nuae076 - Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
https://doi.org/10.1002/hup.2434 - Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
https://doi.org/10.1016/j.jep.2022.115719 - Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
https://doi.org/10.3736/jintegrmed2013056 - Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
https://doi.org/10.1016/j.ctim.2017.06.001 - Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
https://doi.org/10.1089/cap.2018.0146 - Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
https://doi.org/10.1055/s-0034-1375681 - Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.6b04398 - Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
https://doi.org/10.1002/ptr.5622 - Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2014.10.009 - Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2018.03.041 - El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
https://doi.org/10.3390/nu14030597 - Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
https://doi.org/10.3390/molecules26051237 - Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L - Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
https://scholar.google.com/scholar?q=Avicenna - Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
https://scholar.google.com/scholar?q=Crocus%20sativus%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
https://doi.org/10.1016/j.jad.2014.11.035 - Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
https://doi.org/10.1055/a-0660-9565 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
https://doi.org/10.3389/fnut.2024.1349006 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ - Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
https://bygl.osu.edu/node/1458
- Faghfoori, Z., Javadivala, Z., Khalili, Y. and Malek Mahdavi, A (2023) 'Effects of Trigonella foenum-graecum (fenugreek) on rheumatoid arthritis: a systematic review', Immunopharmacology and Immunotoxicology, 45(5), pp. 626-634. doi:10.1080/08923973.2023.2202298 Meta-analysis / review
https://doi.org/10.1080/08923973.2023.2202298 - Ouzir, M., El Bairi, K. and Amzazi, S (2016) 'Toxicological properties of fenugreek (Trigonella foenum graecum)', Food and Chemical Toxicology, 96, pp. 145-154. doi:10.1016/j.fct.2016.08.003 Meta-analysis / review
https://doi.org/10.1016/j.fct.2016.08.003 - Rao, A., Steels, E., Inder, W.J., Abraham, S. and others (2016) 'Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study', The Aging Male, 19(2), pp. 134-142. doi:10.3109/13685538.2015.1135323 Randomized trial
https://doi.org/10.3109/13685538.2015.1135323 - Avalos-Soriano, A., De la Cruz-Cordero, R., Rosado, J.L. and Garcia-Gasca, T (2016) '4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity', Molecules, 21(11), pp. 1596. doi:10.3390/molecules21111596 Preclinical
https://doi.org/10.3390/molecules21111596 - Neelakantan, N., Narayanan, M., de Souza, R.J. and van Dam, R.M (2014) 'Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials', pp. 7. Meta-analysis / review
https://scholar.google.com/scholar?q=Effect%20of%20fenugreek%20%28Trigonella%20foenum-graecum%20L.%29%20intake%20on%20glycemia%3A%20a%20meta-analysis%20of%20clinical%20trials - Nagulapalli Venkata, K.C., Swaroop, A., Bagchi, D. and Bishayee, A (2017) 'A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion', Molecular Nutrition & Food Research, 61(6), pp. 1600950. doi:10.1002/mnfr.201600950 Meta-analysis / review
https://doi.org/10.1002/mnfr.201600950 - Ulbricht, C., Basch, E., Burke, D., Cheung, L. and others (2007) 'Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration', Journal of Herbal Pharmacotherapy, 7(3-4), pp. 143-177. doi:10.1080/15228940802142852 Meta-analysis / review
https://doi.org/10.1080/15228940802142852 - El Bairi, K., Ouzir, M., Agnieszka, N. and Khalki, L (2017) 'Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets', Biomedicine & Pharmacotherapy, 90, pp. 479-491. doi:10.1016/j.biopha.2017.03.071 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2017.03.071 - Piao, C.H., Bui, T.T., Song, C.H., Shin, H.S. and others (2017) 'Trigonella foenum-graecum alleviates airway inflammation of allergic asthma in ovalbumin-induced mouse model', Biochemical and Biophysical Research Communications, 482(4), pp. 1284-1288. doi:10.1016/j.bbrc.2016.12.029 Preclinical
https://doi.org/10.1016/j.bbrc.2016.12.029 - Asif, M., Yousaf, H.M., Saleem, M., Saadullah, M. and others (2021) 'Trigonella foenum-graecum Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-alpha', Anti-Cancer Agents in Medicinal Chemistry, 21(11), pp. 1460-1471. doi:10.2174/1871520620666201005100132 Preclinical
https://doi.org/10.2174/1871520620666201005100132 - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Kumar, P. and Bhandari, U (2013) 'Protective effect of fenugreek (Trigonella foenum-graecum L.) seeds in experimentally-induced myocardial infarction', 23(2), pp. 255--261. Traditional / reference
https://scholar.google.com/scholar?q=Protective%20effect%20of%20fenugreek%20%28Trigonella%20foenum-graecum%20L.%29%20seeds%20in%20experimentally-induced%20myocardial%20infarction - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Neelakantan, N., Narayanan, M., de Souza, R.J. and van Dam, R.M (2014) 'Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials', Nutrition Journal, 13, pp. 7. doi:10.1186/1475-2891-13-7 Meta-analysis / review
https://doi.org/10.1186/1475-2891-13-7 - Kim, J., Noh, W., Kim, A., Choi, Y. and Kim, Y.S (2023) 'The effect of fenugreek in type 2 diabetes and prediabetes: a systematic review and meta-analysis of randomized controlled trials', International Journal of Molecular Sciences, 24(18), pp. 13999. doi:10.3390/ijms241813999 Meta-analysis / review
https://doi.org/10.3390/ijms241813999 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126 - Daryabeygi-Khotbehsara, R., Golzarand, M., Ghaffari, M.P. and Djafarian, K (2017) 'Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis', Complementary Therapies in Medicine, 35, pp. 6-13. doi:10.1016/j.ctim.2017.08.016 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2017.08.016
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.